Male breast cancer: Risk factors, diagnosis, and management (review)

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1115-1120

  Johansen Taber, Katherine A ^a   Morisy, Lee R ^b   Osbahr III, Albert J ^c   Dickinson, Barry D ^a  

^a AMERICAN MEDICAL ASSOCIATION   (United States)

^b BAPTIST MEMORIAL HOSPITAL   (United States)

^c Catawba Valley Medical Center   (United States)

Author keywords

BRCA; Genetic testing; Male breast cancer; Mammography

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ANDROGEN DEFICIENCY; AWARENESS; BREAST CANCER; BREAST SELF EXAMINATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HUMAN; MALE BREAST CANCER; MAMMOGRAPHY; MASTECTOMY; OBESITY; OCCUPATIONAL HAZARD; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK FACTOR;

BREAST NEOPLASMS, MALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MAMMOGRAPHY; MASS SCREENING; RISK FACTORS;

EID: 78149295951     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000962     Document Type: Review

References (71)

1. American Cancer Society: Breast Cancer Facts & Figures 2009-2010. http://ww2.cancer.org/downloads/STT/F861009- final%209-08-09.pdf. Accessed 07-06-2010.
2. Anderson WF, Jatoi I, Tse J and Rosenberg PS: Male breast cancer: A population-based comparison with female breast cancer. J Clin Oncol 28: 232-239, 2010.
3. Contractor KB, Kaur K, Rodrigues GS, Kulkarni DM and Singhal H: Male breast cancer: is the scenario changing. World J Surg Oncol 6: 58, 2008.
4. Fentiman IS, Fourquet A and Hortobagyi GN: Male breast cancer. Lancet 367: 595-604, 2006.
5. Hines SL, Tan W, Larson JM, Thompson KM, Jorn HK and Files JA: Evaluation of breast masses in older men. Geriatrics 63: 19-24, 2008.
6. Malani AK: Male breast cancer: a different disease than female breast cancer? South Med J 100: 197, 2007.
7. Lanitis S, Rice AJ, Vaughan A, Cathcart P, Filippakis G, Al Mufti R, et al: Diagnosis and management of male breast cancer. World J Surg 32: 2471-2476, 2008.
8. Meijer-van Gelder ME, Look MP, Bolt-de Vries J, Peters HA, Klijn JG and Foekens JA: Clinical relevance of biologic factors in male breast cancer. Breast Cancer Res Treat 68: 249-260, 2001.
9. Ottini L, Palli D, Rizzo S, Federico M, Bazan V and Russo A: Male breast cancer. Crit Rev Oncol Hematol 73: 141-155, 2010.
10. Muir D, Kanthan R and Kanthan SC: Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 127: 36-41, 2003.
11. Czene K, Bergqvist J, Hall P and Bergh J: How to treat male breast cancer. Breast 16: S147-S154, 2007.
12. Giordano SH, Cohen DS, Buzdar AU, Perkins G and Hortobagyi GN: Breast carcinoma in men: a population-based study. Cancer 101: 51-57, 2004.
13. Mohamad HB and Apffelstaedt JP: Counseling for male BRCA mutation carriers: a review. Breast 17: 441-450, 2008.
14. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182, 2002.
15. Liede A, Karlan BY and Narod SA: Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22: 735-742, 2004.
16. Levy-Lahad E and Friedman E: Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 96: 11-15, 2007.
17. Daly MB: The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns 18: 42-48, 2009.
18. Petrucelli N, Daly MB, Culver JOB and Feldman GL: Gene Reviews: BRCA1 and BRCA2 Hereditary Breast/Ovarian Cancer. 6-19-2007. http://www.ncbi.nlm.nih.gov/ bookshelf/ br.fcgi?book=gene&part=brca1. Accessed 03-17-2009.
19. Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al: Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66: 8297-8308, 2006.
20. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al: Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98: 1694-1706, 2006.
21. Tai YC, Domchek S, Parmigiani G and Chen S: Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99: 1811-1814, 2007.
22. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60: 313-319, 1997.
23. Miolo G, Puppa LD, Santarosa M, De Giacomi C, Veronesi A, Bidoli E, et al: Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy. BMC Cancer 6: 156, 2006.
24. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, et al: Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60: 1079-1084, 1997.
25. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689, 1998.
26. Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, et al: BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat 116: 577-586, 2009.
27. Hultborn R, Hanson C, Kopf I, Verbiene I, Warnhammar E and Weimarck A: Prevalence of Klinefelter's syndrome in male breast cancer patients. Anticancer Res 17: 4293-4297, 1997.
28. Agrawal A, Ayantunde AA, Rampaul R and Robertson JF: Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103: 11-21, 2007. (Pubitemid 46653271)
29. Brinton LA, Richesson DA, Gierach GL, Lacey JV Jr, Park Y, Hollenbeck AR, et al: Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 100: 1477-1481, 2008.
30. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al: Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 93: 231-233, 1998.
31. American Medical Association Council on Science and Public Health: CSAPH Report 2 (A-06): Ionizing Radiation Exposure in the Medical Setting. 2006. http://www.ama-assn.org/ama/noindex/ about-ama/16406.shtml. Accessed 01-19-2009.
32. Sasco AJ, Lowenfels AB and Pasker de Jong P: Epidemiology of male breast cancer: a meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53: 538-549, 1993.
33. Dicker AP: The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy. Lancet Oncol 4: 30-36, 2003.
34. Ron E, Ikeda T, Preston DL and Tokuoka S: Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst 97: 603-605, 2005.
35. McLaughlin JK, Malker HS, Blot WJ, Weiner JA, Ericsson JL and Fraumeni JF Jr: Occupational risks for male breast cancer in Sweden. Br J Ind Med 45: 275-276, 1988.
36. Hansen J: Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med 37: 349-352, 2000.
37. Koc M and Polat P: Epidemiology and aetiological factors of male breast cancer: a ten years retrospective study in eastern Turkey. Eur J Cancer Prev 10: 531-534, 2001.
38. Casagrande JT, Hanisch R, Pike MC, Ross RK, Brown JB and Henderson BE: A case-control study of male breast cancer. Cancer Res 48: 1326-1330, 1988.
39. Brinton LA, Carreon JD, Gierach GL, McGlynn KA and Gridley G: Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat 119: 185-192, 2010.
40. Ewertz M, Holmberg L, Tretli S, Pedersen BV and Kristensen A: Risk factors for male breast cancer - a case-control study from Scandinavia. Acta Oncol 40: 461-471, 2001.
41. Hsing AW, McLaughlin JK, Cocco P, Co Chien HT and Fraumeni JF Jr: Risk factors for male breast cancer (United States). Cancer Causes Control 9: 269-275, 1998.
42. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis V.I.2010. 2008. http://www.nccn.org/professionals/ physician-gls/PDF/breast-screening.pdf. Accessed 11-17-2009.
43. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, et al: American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 53: 141-169, 2003.
44. U.S. Preventive Services Task Force: Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 151: 716-326, 2009.
45. Nemec CF, Listinsky J and Rim A: How should we screen for breast cancer? Mammography, ultrasonography, MRI. Cleve Clin J Med 74: 897-904, 2007.
46. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian V.I.2009. 2009. http://www. nccn.org/professionals/physician-gls/PDF/genetics-screening. pdf. Accessed 11-17-2009.
47. U.S. Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143: 355-361, 2005.
48. ASCO Working Group on Genetic Testing for Cancer Susceptibility: American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility. J Clin Oncol 21: 2397-2406, 2009.
49. Hines SL, Tan WW, Yasrebi M, DePeri ER and Perez EA: The role of mammography in male patients with breast symptoms. Mayo Clin Proc 82: 297-300, 2007.
50. Evans GF, Anthony T, Turnage RH, Schumpert TD, Levy KR, Amirkhan RH, et al: The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg 181: 96-100, 2001.
51. Borgen PI, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, et al: Current management of male breast cancer. A review of 104 cases. Ann Surg 215: 451-457, 1992.
52. Hanavadi S, Monypenny IJ and Mansel RE: Is mammography overused in male patients? Breast 15: 123-126, 2006.
53. Vetto J, Schmidt W, Pommier R, DiTomasso J, Eppich H, Wood W, et al: Accurate and cost-effective evaluation of breast masses in males. Am J Surg 175: 383-387, 1998. (Pubitemid 28213450)
54. Patterson SK, Helvie MA, Aziz K and Nees AV: Outcome of men presenting with clinical breast problems: the role of mammography and ultrasound. Breast J 12: 418-423, 2006.
55. Volpe CM, Raffetto JD, Collure DW, Hoover EL and Doerr RJ: Unilateral male breast masses: cancer risk and their evaluation and management. Am Surg 65: 250-253, 1999.
56. Gunhan-Bilgen I, Bozkaya H, Ustun EE and Memis A: Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol 43: 246-255, 2002.
57. Munn S: When should men undergo mammography? AJR Am J Roentgenol 178: 1419-1420, 2002.
58. Beery TA and Williams JK: Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genet Test 11: 111-123, 2007.
59. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L and Legius E: Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 116A: 11-19, 2003.
60. Hallowell N, Arden-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, et al: Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health Illn 28: 969-988, 2006.
61. McAllister MF, Evans DG, Ormiston W and Daly P: Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet 5: 739-744, 1998.
62. Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A and Garber JE: Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 24: 700-706, 2006.
63. De Cicco C, Baio SM, Veronesi P, Trifiro G, Ciprian A, Vento A, et al: Sentinel node biopsy in male breast cancer. Nucl Med Commun 25: 139-143, 2004.
64. Goss PE, Reid C, Pintilie M, Lim R and Miller N: Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 85: 629-639, 1999.
65. Cutuli B, Lacroze M, Dilhuydy JM, Velten M, De Lafontan B, Marchal C, et al: Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A: 1960-1964, 1995.
66. Golshan M, Rusby J, Dominguez F and Smith BL: Breast conservation for male breast carcinoma. Breast 16: 653-656, 2007.
67. Goyal A, Horgan K, Kissin M, Yiangou C, Sibbering M, Lansdown M, et al: Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 30: 480-483, 2004. (Pubitemid 38701867)
68. Meguerditchian AN, Falardeau M and Martin G: Male breast carcinoma. Can J Surg 45: 296-302, 2002.
69. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, et al: Adjuvant systemic therapy for male breast carcinoma. Cancer 104: 2359-2364, 2005.
70. Patel HZ II, Buzdar AU and Hortobagyi GN: Role of adjuvant chemotherapy in male breast cancer. Cancer 64: 1583-1585, 1989.
71. El Tamer MB, Komenaka IK, Troxel A, Li H, Joseph KA, Ditkoff BA, et al: Men with breast cancer have better disease-specific survival than women. Arch Surg 139: 1079-1082, 2004.